Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 19 July 2005
Vol. 2005, Issue 293, p. cm8
[DOI: 10.1126/stke.2932005cm8]

CONNECTIONS MAP OVERVIEWS

Interleukin-13 (IL-13) Pathway

Ann Kelly-Welch1, Erica M. Hanson2, and Achsah D. Keegan1*

1 Program in Oncology, Marlene and Stewart Greenebaum Cancer Center and Department of Microbiology and Immunology, University of Maryland, Baltimore, USA.
2 Department of Biology, University of Maryland Baltimore County, Catonsville, MD, USA.

stkecm;CMP_7786

Abstract: Interleukin-13 (IL-13), like IL-4, is a cytokine produced by TH2 type helper T cells in response to signaling through the T cell antigen receptor and by mast cells and basophils upon cross-linkage of the high-affinity receptor for immunoglobulin E (IgE). It is also produced by activated eosinophils. IL-13 induces many of the same responses as IL-4 and shares a receptor subunit with IL-4. IL-13 has been implicated in airway hypersensitivity and mucus hypersecretion, inflammatory bowel disease, and parasitic nematode expulsion.

*Corresponding author. E-mail, akeegan{at}som.umaryland.edu

Citation: A. Kelly-Welch, E. M. Hanson, A. D. Keegan, Interleukin-13 (IL-13) Pathway. Sci. STKE 2005, cm8 (2005).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Regulation of inflammation by interleukin-4: a review of "alternatives".
I. G. Luzina, A. D. Keegan, N. M. Heller, G. A. W. Rook, T. Shea-Donohue, and S. P. Atamas (2012)
J. Leukoc. Biol. 92, 753-764
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882